Trials / Unknown
UnknownNCT05660889
Adrenal Vein Sampling as a Tool to Identify Biomarkers That Aid the Diagnosis of Adrenocortical Carcinoma
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 25 (estimated)
- Sponsor
- Erasmus Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
The goal of this observational pilot study is to explore whether we can identify biomarkers predictive for the diagnosis of adrenocortical carcinoma in blood. Five participants who are suspected to have adrenocortical carcinoma will undergo an adrenal vein sampling in order to obtain a blood sample from the adrenal vein. This blood sample will be analyzed and compared to blood samples taken from the adrenal vein of 20 control patients, which are patients who do not have adrenocortical carcinoma. The blood samples of the control patients will be drawn during routine medical care.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Blood sampling. | Blood samples from both study groups, taken during an adrenal vein sampling, will be compared across the groups. |
Timeline
- Start date
- 2022-10-23
- Primary completion
- 2024-09-01
- Completion
- 2024-12-31
- First posted
- 2022-12-21
- Last updated
- 2022-12-21
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT05660889. Inclusion in this directory is not an endorsement.